Skip to main content
Log in

Correlation of allelic losses and clinicopathological factors in primary breast cancers

  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Human breast cancers frequently show allelic loss or loss of heterozygosity (LOH) at specific chromosomal regions. To understand the possible role of these genetic alterations in tumor development and progression, we examined LOH at loci on chromosomal arms lp, 3p, 11p, 13q, 16q, 18q, and 22q in 140 to 246 cases of primary breast cancers and compared it with lymph node metastasis, histological type, tumor stage, estrogen receptor (ER) and progesterone receptor (PgR) status. LOH at 1p22-31 correlated with lymph node metastasis and a tumor size of greater than 2 cm. LOH at 13ql2-14 and 18q21 were most frequently observed in tumors of the solid-tubular type. LOH at 1p34-36 was more frequent in tumors of the scirrhous and solidtubular types than in other less aggressive histological types. Furthermore, a significant association was observed between LOH at 3pl4-21, 11p11-15 and 13ql2-14 and the absence of progesterone receptors. These results suggest that some clinical characteristics of breast cancers are determined by loss of tumor suppressor genes present at specific chromosomal regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

LOH:

Loss of heterozygosity

ER:

Estrogen receptor

PgR:

Progesterone receptor

References

  1. Emi M, Nakamura Y: Positional cloning of breast cancer-rerated gene.Jpn J Hum Genet 39:30, 1994.

    Google Scholar 

  2. Emi M, Miki Y, Nakamura Y: Genetic alteration and diagnosis in human breast cancer.Jpn J Hum Genet 42:34, 1997.

    Google Scholar 

  3. Emi M, Matsumoto S, Iida A: Genetic alteration in breast cancer.Jpn J Hum Genet 43, 1998. In press.

  4. Nakamura Y: Multi-step carcinogen of colorectal cancer.Jpn J Hum Genet 38:23, 1993.

    Google Scholar 

  5. Nakamura Y: Application of DNA markers to clinical genetics.Jpn J Hum Genet 41:1–14, 1996.

    Article  PubMed  Google Scholar 

  6. Sato T, Tanigami A, Yamakawa K,et al: Alleletype of breast cancer; Cumulative allele losses promote tumor progression in primary breast cancer.Cancer Res 50:7184–7189, 1990.

    PubMed  CAS  Google Scholar 

  7. Sato ?, Akiyama F, Sakamoto G,et al: Accumlation of genetic alterations and progression of primary breast cancer.Cancer Res 51:5794–5799, 1991.

    PubMed  CAS  Google Scholar 

  8. Takita K, Sato T, Miyagi M,et al: Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.Cancer Res 52:3914–3917, 1992.

    PubMed  CAS  Google Scholar 

  9. Harada Y, Katagiri T, Ito I,et al: Genetic studies of 457 breast cancers; Clinicopathologic parameters compared with genetic alterations.Cancer 74:2281–2286, 1994.

    Article  PubMed  CAS  Google Scholar 

  10. Ito I, Yoshimoto M, Iwase T,et al: Association of genetic alterations on chromosome 17 and loss of hormone receptor in breast cancer.Br J Cancer 71: 438–441, 1995.

    PubMed  CAS  Google Scholar 

  11. Tsukamoto K, Ito N, Yoshimoto M,et al: Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas.Cancer 78:1929–1934, 1996.

    Article  PubMed  CAS  Google Scholar 

  12. lida A, Isobe R, Yoshimoto M,et al: Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22.Br J Cancer 75:264–267, 1997.

    Google Scholar 

  13. Tsukamoto K, Ito N, Yoshimoto M, et al: Allelic loss on chromosome lp is associated with progression and lymph node metastasis of primary breast cancer.Cancer, 1997. In press.

  14. Matsumoto S, Kasumi F, Sakamoto G,et al: Detailed deletion mapping of chromosome arm 3p in breast cancers; A2-cM region on 3p 14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors.Genes Chrom Cancer 20:1–7, 1997.

    Article  Google Scholar 

  15. Nakata T, Yoshinoto M, Kasumi F, et al: Identification of a new commonly deleted region within a 2-cM interval of 11p11 in breast cancer.Eur J Cancer, 1997. In press.

  16. Yokota T, Matsumoto S, Yoshimoto M,et al: Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21.Jpn J Cancer Res 88:959–964, 1997.

    PubMed  CAS  Google Scholar 

  17. Iida A, Kurose K, Isobe R, et al: Mapping of a new target of allelic loss to a 2-cM interval at 22ql3.1 in primary breast cancer. Genes Chrom Cancer, 1998. In press.

  18. Murray JC, Buetow KH, Weber JL,et al: A comprehensive human linkage map with centimorgan density.Science 265:2049–2054, 1994.

    Article  PubMed  CAS  Google Scholar 

  19. Gyapay G, Morissette J, Vignai A,et al: The 1993–94 Genethon human genetic linkage map.Nat Genet 7: 246–339, 1994.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Emi, M., Matsumoto, S., Iida, A. et al. Correlation of allelic losses and clinicopathological factors in primary breast cancers. Breast Cancer 4, 243–246 (1997). https://doi.org/10.1007/BF02966514

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02966514

Key words

Navigation